These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Pharmacokinetics and pharmacodynamics of antifungal drugs in children]. Jullien V Arch Pediatr; 2011 May; 18 Suppl 1():S42-7. PubMed ID: 21596286 [TBL] [Abstract][Full Text] [Related]
3. Recent approaches to antifungal therapy for invasive mycoses. Mathew BP; Nath M ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067 [TBL] [Abstract][Full Text] [Related]
4. How can we bolster the antifungal drug discovery pipeline? Jampilek J Future Med Chem; 2016 Aug; 8(12):1393-7. PubMed ID: 27464242 [No Abstract] [Full Text] [Related]
5. Echinocandins: are they all the same? Mukherjee PK; Sheehan D; Puzniak L; Schlamm H; Ghannoum MA J Chemother; 2011 Dec; 23(6):319-25. PubMed ID: 22233814 [TBL] [Abstract][Full Text] [Related]
7. A clinical review of echinocandins in pediatric patients. VandenBussche HL; Van Loo DA Ann Pharmacother; 2010 Jan; 44(1):166-77. PubMed ID: 20009006 [TBL] [Abstract][Full Text] [Related]
11. Medical claims and current applications of the potent echinocandin antifungals. Smith L; Lu SE Recent Pat Antiinfect Drug Discov; 2010 Jan; 5(1):58-63. PubMed ID: 19929842 [TBL] [Abstract][Full Text] [Related]
12. [Antifungal agents in the treatment of systemic infections: Relevance of mechanism of action, activity profile and resistances]. Cuenca-Estrella M Rev Esp Quimioter; 2010 Dec; 23(4):169-76. PubMed ID: 21191554 [TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic implications for use of antifungal agents. Lewis RE Curr Opin Pharmacol; 2007 Oct; 7(5):491-7. PubMed ID: 17616480 [TBL] [Abstract][Full Text] [Related]
14. Micafungin: a sulfated echinocandin. Hashimoto S J Antibiot (Tokyo); 2009 Jan; 62(1):27-35. PubMed ID: 19132058 [TBL] [Abstract][Full Text] [Related]
15. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Fera MT; La Camera E; De Sarro A Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707 [TBL] [Abstract][Full Text] [Related]
16. [Micafungin: new challenges, new possibilities in the treatment of invasive fungal infection]. Pemán J; Torre-Cisneros J Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():1-2. PubMed ID: 21420569 [No Abstract] [Full Text] [Related]
17. New facets of antifungal therapy. Chang YL; Yu SJ; Heitman J; Wellington M; Chen YL Virulence; 2017 Feb; 8(2):222-236. PubMed ID: 27820668 [TBL] [Abstract][Full Text] [Related]
18. New antifungal agents in pediatric practice. Das S; Shivaprakash MR; Chakrabarti A Indian Pediatr; 2009 Mar; 46(3):225-31. PubMed ID: 19346570 [TBL] [Abstract][Full Text] [Related]
19. Pediatric antifungal agents. Cohen-Wolkowiez M; Moran C; Benjamin DK; Smith PB Curr Opin Infect Dis; 2009 Dec; 22(6):553-8. PubMed ID: 19741525 [TBL] [Abstract][Full Text] [Related]
20. Antifungal azoles: old and new. Blyth CC Pediatr Infect Dis J; 2011 Jun; 30(6):506-7. PubMed ID: 21587027 [No Abstract] [Full Text] [Related] [Next] [New Search]